NIH Director Dr. Jay Bhattacharya has publicly acknowledged that there is currently no evidence that COVID-19 booster shots reduce symptoms or severity of illness in individuals who have already had a prior infection.

The admission came during a recent discussion in which neuroscientist Andrew Huberman suggested that “some people may want to take the COVID vaccine to reduce symptom severity, not just to avoid death.” 

Bhattacharya responded bluntly: “There is no evidence that it would do that at this point.”

While early versions of the COVID vaccines were rolled out under claims of reducing hospitalization and death, Bhattacharya clarified that the boosters being administered today are fundamentally different vaccines.

Unlike the original shots that were launched in December 2020 alongside massive global propaganda campaigns, the current boosters lack the robust, large-scale clinical trials that could demonstrate meaningful clinical benefits.

“The boosters are a different vaccine,” Bhattacharya stated. “They have been approved on the basis of relatively small-scale studies asking whether they produce antibodies—not things that clinically matter to people.” Watch:

In plain terms: boosters have been greenlit based on lab results, not real-world outcomes. The metrics being used—such as antibody production—may sound reassuring on paper, but they don’t answer the questions most Americans care about:

According to Bhattacharya, the answer remains uncertain. In fact, he noted that the FDA only recently decided to demand stronger evidence from pharmaceutical companies before approving future boosters—raising uncomfortable questions about how previous booster campaigns were authorized and promoted.

“It shouldn’t just be a routine thing. This is not a flu shot,” he emphasized. “The regulatory framework that governs flu shots is based on decades of experience with the flu vaccine.”

This startling admission echoes long-held concerns in the vaccine-skeptical community—that the COVID booster campaign has been driven more by politics, profit, and panic than by sound medical science.

With billions in taxpayer funds funneled into fast-tracked pharmaceutical contracts, and mandates pushed on the public under questionable pretenses, critics say this moment should serve as a wake-up call.

“They told us to ‘trust the science,’” said one independent physician on X (formerly Twitter). “But now the science is finally catching up, and it’s telling a very different story.”

As more people wake up to the reality that natural immunity remains vastly understudied and underacknowledged, the latest revelations will likely fuel renewed skepticism around boosters, mandates, and the ever-shifting public health narrative.